Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

David A. Barbie(Dana-Farber Cancer Institute), William C. Hahn(Broad Institute), Etienne Meylan(Université Libre de Bruxelles), Sebastian Hoersch(Allen Institute), Kathrin Michel(Max Planck Society), David M. Sabatini(Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry), Pablo Tamayo(Dana-Farber Cancer Institute), Jesse S. Boehm(Massachusetts Institute of Technology), Eric S. Lander(Broad Institute), Péter Sandy(Allen Institute), David M. Livingston(Dana-Farber Cancer Institute), Jan H. Reiling(The University of Texas MD Anderson Cancer Center), Piyush B. Gupta(Broad Institute), Serena J. Silver(Broad Institute), Claudia Scholl(German Cancer Research Center), Qing Sheng(Zhejiang Sci-Tech University), Barbara A. Weir(Weatherford College), Susan E. Moody(Broad Institute), Martin L. Sos(German Cancer Research Center), Matthew Meyerson(Broad Institute), Roman K. Thomas(University of Cologne), Ben S. Wittner(Broad Institute), Tyler Jacks(Massachusetts Institute of Technology), Raymond Wadlow(Broad Institute), Jill P. Mesirov(University of California San Diego), David E. Root(Broad Institute), Craig H. Mermel(California University of Pennsylvania), So Young Kim(Chungbuk National University), Ian F. Dunn(University of Oklahoma), Sridhar Ramaswamy(Harvard University), Hanh Le(Broad Institute), D. Gary Gilliland(Brigham and Women's Hospital), Edmond M. Chan(Broad Institute), Anna C. Schinzel(Broad Institute), Stefan Fröhling(German Cancer Research Center)
Nature
October 21, 2009
Cited by 4,191


Related Papers